DrugDashboards

Market view

dopamine hydrochloride in dextrose

4 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “other.

Same drug class

Other molecules FDA puts in Catecholamine, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dopamine hydrochloride in dextrose in shortage right now?
Yes. FDA currently lists Dopamine hydrochloride in dextrose in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
Who makes Dopamine hydrochloride in dextrose?
2 companies have marketed Dopamine hydrochloride in dextrose in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • Planned discontinuationDopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (NDC 0409-7809-24)Aug 27, 2025
  • In shortage nowDopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)Nov 6, 2017

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.